Register entry

Neurelis, Inc

Data as of · How to read this entry

Registered sites
0
Active NDC listings
4
Live patents
24
Exclusivities
1
Countries
0
Catalogue

Drug listings by form and route

4

4 active NDC listings: 4 human prescription drug. By marketing category: NDA 4.

Dosage formNDCs
spray4
RouteNDCs
nasal4
Labeller name on the listingNDCs
neurelis, inc4
Exclusivity

Patents and exclusivities

24
PatentProductCoversExpiry
11241414VALTOCOdiazepamproductMar 2029
11793786VALTOCOdiazepamproductMar 2029
12268664VALTOCOdiazepamproductMar 2029
12521400VALTOCOdiazepamproductMar 2029
8895546VALTOCOdiazepamproductMar 2029
12337061VALTOCOdiazepamuseJun 2032
12324852VALTOCOdiazepamuseOct 2032
12599611VALTOCOdiazepamuseJun 2042
ProductExclusivityUntil
VALTOCODIAZEPAMNPP New patient populationApr 2028
Catalogue

Marketed products

4
BrandGeneric nameForm / routeNDC
Valtocodiazepamspray, nasal72252-505NDA
Valtocodiazepamspray, nasal72252-510NDA
Valtocodiazepamspray, nasal72252-515NDA
Valtocodiazepamspray, nasal72252-520NDA
Compare

Other companies listing diazepam

Enquiry

Common questions

Is Neurelis, Inc FDA approved?
Neurelis, Inc holds no registered establishment of its own; 4 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Neurelis, Inc make?
4 products are listed under Neurelis, Inc in the openFDA NDC Directory, most often as spray. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.